Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,665 | -8,669 | -25,447 | -23,535 | -14,768 |
| Depreciation Amortization | 843 | 397 | 2,120 | 1,605 | 1,124 |
| Accounts receivable | 179 | -9 | 598 | 718 | 477 |
| Other Working Capital | -2,436 | -422 | 3,005 | 7,987 | 7,452 |
| Other Operating Activity | -930 | 543 | 3,241 | 2,554 | 1,527 |
| Operating Cash Flow | $-15,009 | $-8,160 | $-16,483 | $-10,671 | $-4,188 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 179 | 1,214 | 3,879 | 2,986 | 850 |
| PPE Investments | 2,810 | -130 | -3,138 | -3,014 | -2,331 |
| Purchase Of Investment | N/A | N/A | -150 | -150 | -150 |
| Other Investing Activity | -109 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $2,880 | $1,084 | $591 | $-178 | $-1,631 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 600 | N/A | N/A |
| Debt Repayment | -774 | -253 | -952 | -714 | -460 |
| Common Stock Issued | 28,408 | 20,128 | 17,700 | 17,171 | 651 |
| Other Financing Activity | -1,599 | 0 | -561 | 0 | 0 |
| Financing Cash Flow | $26,035 | $19,875 | $16,787 | $16,457 | $191 |
| Beginning Cash Position | 8,902 | 8,902 | 8,007 | 8,007 | 8,007 |
| End Cash Position | 22,808 | 21,701 | 8,902 | 13,615 | 2,379 |
| Net Cash Flow | $13,906 | $12,799 | $895 | $5,608 | $-5,628 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,009 | -8,160 | -16,483 | -10,671 | -4,188 |
| Capital Expenditure | -365 | -130 | -3,138 | -3,014 | -2,331 |
| Free Cash Flow | -15,374 | -8,290 | -19,621 | -13,685 | -6,519 |